Andere Sprachen Moderna, Inc.

Aktien

A2N9D9

US60770K1079

MRNA

Pharmazeutika

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:06:25 13.03.2026			% 5 Tage	Veränd. 1. Jan.
52,18 ^USD	-2,27 %		-0,60 %	+77,03 %

12:03	GSK erhàlt US-FDA-Zulassung für erweiterten Einsatz des RSV-Impfstoffs	RE
11.03.	BioNTech erschüttert durch den Abgang seines legendären Gründerduos

Andere Sprachen

12:03	GSK gets US FDA approval for expanded use of RSV vaccine
05.03.	US stocks close up on Iran diplomacy hopes; tech leads rebound
04.03.	Health Care Up, But not by Much, on Cyclical Bias - Health Care Roundup
04.03.	Equities Rise on Upbeat Data as Markets Look Past Middle East Conflict
04.03.	Wall Street progresse après des signes d'ouverture de l'Iran à des discussions avec Washington
04.03.	US Equity Markets End Higher After Strong Services, Jobs Data
04.03.	Wall Street surmonte les incertitudes liées à la guerre au Moyen-Orient
04.03.	Moderna Shares Rise After Company Enters Settlement Agreement with Arbutus Biopharma, Genevant Sciences
04.03.	Equities Rise Intraday as Markets Parse Macro Data Amid Middle East Conflict
04.03.	US stocks close up on Iran diplomacy hopes; tech leads rebound
04.03.	Wall Street mixed as oil retreat eases inflation fears
04.03.	Top Midday Stories: Bessent Says US to Fortify Gulf Oil Trade, 15% Tariff Rolling Out This Week; CrowdStrike Fiscal Q4 Adjusted Earnings, Revenue Increase
04.03.	Borsa Usa, S&P 500 in rialzo dopo indiscrezioni su contatti segreti Iran con Usa
04.03.	Wall Street sur une note mitigée, le reflux du pétrole apaise les craintes inflationnistes
04.03.	Wall Street se reprend, aidée par une détente des prix du pétrole
04.03.	Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
04.03.	Global markets live: Goldman Sachs, Meta, Intel, Moderna, Adidas…
04.03.	Licht hogere opening Wall Street voorzien
04.03.	Moderna to pay $950m to end litigation
04.03.	Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
04.03.	Moderna va payer 950 millions de dollars pour mettre fin à des litiges
04.03.	USA-Les valeurs à suivre à Wall Street (actualisé)
04.03.	Accordo Moderna, 2,25 miliardi per chiudere la lite sui brevetti
03.03.	Moderna Enters Settlement Agreement with Arbutus Biopharma, Genevant Sciences
03.03.	Moderna 2026 year-end cash and cash equivalents now expected to be in the range of $4.5 billion-$5 billion